16 July 2025NewsAmericasMichael Shuster, Goodwin Law | Erica LoRe, Invivyd | Guy Birkenmeier, New England Biolabs

WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US

LSPN experts from Goodwin Law, Invivyd, and New England Biolabs discuss the challenges of patent eligibility under 35 U.S.C. § 101 in life sciences innovation. The session explores strategies to address obstacles arising from recent court decisions and USPTO guidelines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

American Regent secures rare PI win in Hatch-Waxman dispute

In-house with Bayer: ‘Focus on quality early and stay close to inventors’

Explainer: ARIPO’s role in Plant Variety Protection

J&J sues over schizophrenia drug generic following patent victory

WATCH: The transparency tightrope—balancing innovation, regulation, and IP protection in a new era

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’

Powell Gilbert launches Düsseldorf office with leading patent litigator

Startups toolkit: Why investors want more than patents

WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US

Editor's picks

Editor's picks

More features